Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-17-001770
Filing Date
2017-04-17
Accepted
2017-04-17 14:30:21
Documents
86
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K curr_10k.htm 10-K 532729
2 CERTIFICATION curr_ex311.htm EX-31.1 9882
3 CERTIFICATION curr_ex312.htm EX-31.2 9837
4 CERTIFICATION curr_ex321.htm EX-32.1 2912
5 CERTIFICATION curr_ex322.htm EX-32.2 2910
12 curr_10kimg1.jpg GRAPHIC 2413
  Complete submission text file 0001477932-17-001770.txt   3941607

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mkkn-20161231.xml EX-101.INS 722119
7 XBRL TAXONOMY EXTENSION SCHEMA mkkn-20161231.xsd EX-101.SCH 58138
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mkkn-20161231_cal.xml EX-101.CAL 52481
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mkkn-20161231_def.xml EX-101.DEF 166269
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mkkn-20161231_lab.xml EX-101.LAB 315927
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mkkn-20161231_pre.xml EX-101.PRE 280943
Mailing Address 1620 BEACON PLACE OXNARD CA 93033
Business Address 1620 BEACON PLACE OXNARD CA 93033 805-824-0410
Cure Pharmaceutical Holding Corp. (Filer) CIK: 0001643301 (see all company filings)

EIN.: 371765151 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-204857 | Film No.: 17764275
SIC: 2673 Plastics, Foil & Coated Paper Bags